Sarepta Therapeutics, Inc. Earnings

Sarepta Therapeutics, Inc.’s revenue fell -32.73% since last year same period to $442.93Mn in the Q4 2025. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 10.91% jump in its revenue since last 3-months.

Sarepta Therapeutics, Inc.’s net profit fell -277.84% since last year same period to $-282.85Mn in the Q4 2025. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated -57.18% fall in its net profits since last 3-months.

Sarepta Therapeutics, Inc.’s net profit margin fell -364.35% since last year same period to -63.86% in the Q4 2025. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated -41.72% fall in its net profit margins since last 3-months.

Sarepta Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.05 - a -50.32% fall from last quarter’s estimates.

Sarepta Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -1.05.

Sarepta Therapeutics, Inc.’s earning per share (EPS) fell -288.42% since last year same period to -3.58 in the Q4 2025. This indicates that the Sarepta Therapeutics, Inc. has generated -288.42% annual rate of fall in its earning per share (EPS) in the last 4 quarters.